Artigo Acesso aberto Revisado por pares

Fertility preservation and sperm donation in transgender individuals: The current situation within the French CECOS network

2021; Wiley; Volume: 9; Issue: 6 Linguagem: Inglês

10.1111/andr.13075

ISSN

2047-2927

Autores

Florence Eustache, Véronique Drouineaud, Nicolas Mendes, Béatrice Delépine, Charlotte Dupont, S. Mirallié, Aline Papaxanthos-Roche, Catherine Metzler‐Guillemain, Aurélie Rives‐Feraille, Fanny Magnan, Cécile Grèze, Sylviane Hennebicq, Isabelle Koscinski, Hortense Drapier, Cynthia Frapsauce, Anne Mayeur, Marie‐Ange Carlotti, Joffrey Mons, Françoise Schmitt, Pascale May‐Panloup, Oxana Blagosklonov, Florence Brugnon, Stéphanie Mestres, Rosalie Cabry, Patricia Fauque, Vanessa Loup-Cabaniols, Célia Ravel, Rachel Lévy, Catherine Patrat, Emmanuelle Thibault, Nelly Frydman, Louis Bujan, Catherine Morinière, Bérengère Ducrocq, Nathalie Rives,

Tópico(s)

Sexuality, Behavior, and Technology

Resumo

Many studies reported that reproductive desire could be high among transgender individuals. In France, fertility preservation and sperm donation were very little proposed to transgender individuals until recently, mainly because the Bioethics Law allows the use of assisted reproductive technologies only in infertile couples and prohibits surrogacy. To evaluate the distribution of care on the French territory concerning fertility preservation and sperm donation in transgender individuals. A multicentric national survey was carried out between January 2019 and October 2020 in 28 assisted reproductive technology centres of the French CECOS (Centres d'Etudes et de Conservation des Oeufs et du Sperme) network. Each centre was questioned to find out how many transgender individuals came, were informed and cared for fertility preservation and sperm donation. Concerning fertility preservation, 71.4% of centres received transgender individuals and performed gamete cryopreservation; 581 transgender individuals consulted for fertility preservation. Transgender women were more likely to desire (p < 0.0001) and achieve (p < 0.0001) fertility preservation than transgender men. Concerning sperm donation in couples including a transgender man, 68% of centres offer the complete course from the first consultation to the completion of the assisted reproductive technology cycles; 122 offsprings have been conceived with sperm donation in couples including a transgender man since 1999. Our results showed that even if all centres do not propose fertility preservation or sperm donation in transgender individuals, these assisted reproductive technologies are present throughout the French territory. The major point is that both fertility preservation and sperm donation in transgender individuals have grown significantly and that the care of these patients is improving year after year. In France, most of CECOS centres can take care of transgender individuals for fertility preservation and sperm donation. The French Bioethics Law allows these latter, and transgender individuals can benefit from a financial support of the national health care insurance for fertility preservation and sperm donation.

Referência(s)